References

1. Luft FC. Hypertension as a complex genetic trait. Semin Nephrol 2002;22:115-126.

2. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001;104:545-556.

3. Krushkal J, Ferrell R, Mockrin SC, Turner ST, Sing CF, Boerwinkle E. Genome-wide linkage analyses of systolic blood pressure using highly discordant siblings. Circulation1999;99:1407-1410.

4. Hunt SC, Ellison RC, Atwood LD, Pankow JS, Province MA, Leppert MF. Genome scans for blood pressure and hypertension: the National Heart, Lung, and Blood Institute Family Heart Study. Hypertension 2002;40:1-6.

5. Kristjansson K, Manolescu A, Kristinsson A, et al. Linkage of essential hypertension to chromosome 18q. Hypertension 2002;39:1044-1049.

6. Rice T, Rankinen T, Chagnon YC, et al. Genomewide linkage scan of resting blood pressure: HERI TAGE Family Study. Health, Risk Factors, Exercise Training, and Genetics. Hypertension 2002;39:1037-1043.

7. Levy D, DeStefano AL, Larson MG, et al. Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart study. Hypertension 2000;36:477-483.

8. Caulfield M, Munroe P, Pembroke J, et al. Genome-wide mapping of human loci for essential hypertension. Lancet 2003;361:2118-2123.

9. Kageyama R, Ohkubo H, Nakanishi S. Primary structure of human preangiotensinogen deduced from the cloned cDNA sequence. Biochemistry 1984;23:3603-3609.

10. Corvol P, Jeunemaitre X. Molecular genetics of human hypertension: role of angiotensinogen. Endocr Rev 1997;18:662-677.

11. Gould AB, Green D. Kinetics of the human renin and human substrate reaction. Cardiovasc Res 1971;5:86-89.

12. Fasola AF, Martz BL, Helmer OM. Renin activity during supine exercise in normotensives and hypertensives. J Appl Physiol 1966;21:1709-1712.

13. Watt GC, Harrap SB, Foy CJ, et al. Abnormalities of glucocorticoid metabolism and the renin- angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens 1992;10:473-482.

14. Campbell DJ, Habener JF. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest 1986;78:31-39.

15. Tanimoto K, Sugiyama F, Goto Y, et al. Angiotensinogen-deficient mice with hypotension. J Biol Chem 1994;269:31334-31337.

16. Kim HS, Krege JH, Kluckman KD, et al. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci USA 1995;92:2735-2739.

17. Krege JH, Kim HS, Moyer JS, et al. Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis. Hypertension 1997;29:150-157.

18. Gaillard I, Clauser E, Corvol P. Structure of human angiotensinogen gene. DNA 1989;8:87-99.

19. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992;71:169-180.

20. Jeunemaitre X, Rigat B, Charru A, Houot AM, Soubrier F, Corvol P. Sib pair linkage analysis of renin gene haplotypes in human essential hypertension. Hum Genet 1992;88:301-306.

21. Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Lalouel JM. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet 1992;1:72-75.

22. Bonnardeaux A, Davies E, Jeunemaitre X, et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994;24:63-69.

23. Caulfield M, Lavender P, Newell Price J, Kamdar S, Farrall M, Clark AJ. Angiotensinogen in human essential hypertension. Hypertension 1996;28:1123-1125.

24. Caulfield M, Lavender P, Newell Price J, et al. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest 1995;96:687-692.

25. Schmidt S, Sharma AM, Zilch O, et al. Association of M235T variant of the angiotensinogen gene with familial hypertension of early onset. Nephrol Dial Transplant 1995;10:1145-1148.

26. Hingorani AD, Sharma P, Jia H, Hopper R, Brown MJ. Blood pressure and the M235T polymorphism of the angiotensinogen gene. Hypertension 1996;28:907-911.

27. Kiema TR, Kauma H, Rantala AO, et al. Variation at the angiotensin-converting enzyme gene and angiotensinogen gene loci in relation to blood pressure. Hypertension 1996;28:1070-1075.

28. Borecki IB, Province MA, Ludwig EH, et al. Associations of candidate loci angiotensinogen and angio-tensin-converting enzyme with severe hypertension: The NHLBI Family Heart Study. Ann Epidemiol 1997;7:13-21.

29. Jeunemaitre X, Inoue I, Williams C, et al. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet 1997;60:1448-1460.

30. Schunkert H, Hense HW, Gimenez-Roqueplo AP, et al. The angiotensinogen T235 variant and the use of antihypertensive drugs in a population-based cohort. Hypertension 1997;29:628-633.

31. Tiret L, Blanc H, Ruidavets JB, et al. Gene polymorphisms of the renin-angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: the PEGASE study. Projet d'Etude des Genes de l'Hypertension Arterielle Severe a moderee Essentielle. J Hypertens 1998;16:37-44.

32. Kunz R, Kreutz R, Beige J, Distler A, Sharma AM. Association between the angiotensinogen 235T-variant and essential hypertension in whites: a systematic review and methodological appraisal. Hypertension 1997;30:1331-1337.

33. Hata A, Namikawa C, Sasaki M, et al. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 1994;93:1285-1287.

34. Kamitani A, Rakugi H, Higaki J, et al. Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese. J Hum Hypertens 1994;8:521-524.

35. Iwai N, Shimoike H, Ohmichi N, Kinoshita M. Angiotensinogen gene and blood pressure in the Japanese population. Hypertension 1995;25:688-693.

36. Ishigami T, Umemura S, Tamura K, et al. Essential hypertension and 5' upstream core promoter region of human angiotensinogen gene. Hypertension 1997;30:1325-1330.

37. Bloem LJ, Foroud TM, Ambrosius WT, Hanna MP, Tewksbury DA, Pratt JH. Association of the angiotensinogen gene to serum angiotensinogen in blacks and whites. Hypertension 1997;29:1078-1082.

38. Larson N, Hutchinson R, Boerwinkle E. Lack of association of 3 functional gene variants with hypertension in African Americans. Hypertension 2000;35:1297-1300.

39. Inoue I, Nakajima T, Williams CS, et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997;99:1786-1797.

40. Cvetkovic B, Keen HL, Zhang X, Davis D, Yang B, Sigmund CD. Physiological significance of two common haplotypes of human angiotensinogen using gene targeting in the mouse. Physiol Genomics 2002;11:253-262.

41. Jain S, Tang X, Narayanan CS, et al. Angiotensinogen gene polymorphism at -217 affects basal promoter activity and is associated with hypertension in African-Americans. J Biol Chem 2002;277:36889-36896.

42. Choy B, Roberts SG, Griffin LA, Green MR. How eukaryotic transcription activators increase assembly of preinitiation complexes. Cold Spring Harb Symp Quant Biol 1993;58:199-203.

43. Choy B, Green MR. Eukaryotic activators function during multiple steps of preinitiation complex assembly. Nature 1993;366:531-536.

44. Ptashne M. 1997 Albert Lasker Award for Basic Medical Research. Control of gene transcription: an outline. Nat Med 1997;3:1069-1072.

45. Rosenfeld MG, Glass CK. Coregulator codes of transcriptional regulation by nuclear receptors. J Biol Chem 2001;276:36,865-36,868.

46. Glass CK, Rosenfeld MG. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 2000;14:121-141.

47. LeVan TD, Bloom JW, Bailey TJ, et al. A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol 2001;167:5838-5844.

48. Spek CA, Greengard JS, Griffin JH, Bertina RM, Reitsma PH. Two mutations in the promoter region of the human protein C gene both cause type I protein C deficiency by disruption of two HNF-3 binding sites. J Biol Chem 1995;270:24,216-24,221.

49. Farzaneh-Far A, Davies JD, Braam LA, et al. A polymorphism of the human matrix gamma-carboxyglutamic acid protein promoter alters binding of an activating protein-1 complex and is associated with altered transcription and serum levels. J Biol Chem 2001;276:32466-32473.

50. Narayanan CS, Cui Y, Kumar A. DBP binds to the proximal promoter and regulates liver-specific expression of the human angiotensinogen gene. Biochem Biophys Res Commun 1998;251:388-393.

51. Zhao YY, Zhou J, Narayanan CS, Cui Y, Kumar A. Role of C/A polymorphism at -20 on the expression of human angiotensinogen gene. Hypertension 1999;33:108-115.

52. Narayanan CS, Cui Y, Zhao YY, Zhou J, Kumar A. Orphan receptor Arp-1 binds to the nucleotide sequence located between TATA box and transcriptional initiation site of the human angiotensinogen gene and reduces estrogen induced promoter activity. Mol Cell Endocrinol 1999;148:79-86.

53. Yanai K, Nibu Y, Murakami K, Fukamizu A. A cis-acting DNA element located between TATA box and transcription initiation site is critical in response to regulatory sequences in human angiotensinogen gene. J Biol Chem 1996;271:15981-15986.

54. Cui Y, Narayanan CS, Zhou J, Kumar A. Exon-I is involved in positive as well as negative regulation of human angiotensinogen gene expression. Gene 1998;224:97-107.

55. Sherman CT, Brasier AR. Role of Signal Transducers and Activators of Transcription 1 and -3 in Inducible Regulation of the Human Angiotensinogen Gene by Interleukin-6. Mol Endocrinol 2001;15:441-457.

56. Narayanan CS, Cui Y, Kumar S, Kumar A. cAMP increases the expression of human angiotensinogen gene through a combination of cyclic AMP responsive element binding protein and a liver specific transcription factor. Mol Cell Biochem 2000;212:81-90.

57. Yanai K, Hirota K, Taniguchi-Yanai K, et al. Regulated expression of human angiotensinogen gene by hepatocyte nuclear factor 4 and chicken ovalbumin upstream promoter-transcription factor [In Process Citation]. J Biol Chem 1999;274:34,605-34,612.

58. Brasier AR, Han Y, Sherman CT. Transcriptional regulation of angiotensinogen gene expression. Vitam Horm 1999;57:217-247.

59. Short MK, Clouthier DE, Schaefer IM, Hammer RE, Magnuson MA, Beale EG. Tissue-specific, developmental, hormonal, and dietary regulation of rat phosphoenolpyruvate carboxykinase-human growth hormone fusion genes in transgenic mice. Mol Cell Biol 1992;12:1007-1020.

60. Patel YM, Yun JS, Liu J, McGrane MM, Hanson RW. An analysis of regulatory elements in the phosphoenolpyruvate carboxykinase (GTP) gene which are responsible for its tissue-specific expression and metabolic control in transgenic mice. J Biol Chem 1994;269:5619-5628.

61. Yan SF, Zou YS, Mendelsohn M, et al. Nuclear factor interleukin 6 motifs mediate tissue-specific gene transcription in hypoxia. J Biol Chem 1997;272:4287-4294.

62. Brinkmeier ML, Gordon DF, Dowding JM, et al. Cell-specific expression of the mouse glycoprotein hormone alpha-subunit gene requires multiple interacting DNA elements in transgenic mice and cultured cells. Mol Endocrinol 1998;12:622-633.

63. Cvetkovic B, Yang B, Williamson RA, Sigmund CD. Appropriate tissue- and cell-specific expression of a single copy human angiotensinogen transgene specifically targeted upstream of the HPRT locus by homologous recombination. J Biol Chem 2000;275:1073-1078.

64. Zhu X, Chang YP, Yan D, et al. Associations between hypertension and genes in the renin-angiotensin system. Hypertension 2003;41:1027-1034.

65. Casari G, Barlassina C, Cusi D, et al. Association of the alpha-adducin locus with essential hypertension. Hypertension 1995;25:320-326.

66. Bray MS, Krushkal J, Li L, et al. Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation 2000;101:2877-2882.

67. Dong Y, Zhu H, Sagnella GA, et al. Association between the C825T polymorphism of the G protein beta3-subunit gene and hypertension in blacks. Hypertension 1999;34:1193-1196.

Blood Pressure Health

Blood Pressure Health

Your heart pumps blood throughout your body using a network of tubing called arteries and capillaries which return the blood back to your heart via your veins. Blood pressure is the force of the blood pushing against the walls of your arteries as your heart beats.Learn more...

Get My Free Ebook


Post a comment